Somatropin Injection, Solution
NDC Package 68594-040-99
Package Information
Somatropin injection is various brands of this medication are used for the treatment of one of the following medical conditions: growth failure, growth hormone deficiency, intestinal disorder (short bowel syndrome) or HIV-related weight loss or wasting. This formulation utilizes a injection, solution delivery system. Marketed by Boehringer Ingelheim Rcv Gmbh & Co Kg, this product is identified by NDC 68594-040.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68594 - Boehringer Ingelheim Rcv Gmbh & Co Kg
- 68594-040 -
- 68594-040-99 - 1 mg in 1 BOTTLE
- 68594-040 -
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68594-040-99 identifies a specific commercial package of 1 mg in 1 bottle of Somatropin (UNFINISHED drug), a bulk ingredient labeled by Boehringer Ingelheim Rcv Gmbh & Co Kg. This injection, solution is formulated for use and contains somatropin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Boehringer Ingelheim Rcv Gmbh & Co Kg on September 03, 2020. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Various brands of this medication are used for the treatment of one of the following medical conditions: growth failure, growth hormone deficiency, intestinal disorder (short bowel syndrome) or HIV-related weight loss or wasting. Somatropin is also used to increase height in children with certain disorders (such as Noonan syndrome, Turner syndrome, idiopathic short stature).
How is this Boehringer Ingelheim Rcv Gmbh & Co Kg product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68594004099. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.